Synergistic effect of immune checkpoint blockade and anti-angiogenesis in cancer treatment

M Yi, D Jiao, S Qin, Q Chu, K Wu, A Li - Molecular cancer, 2019 - Springer
Immune checkpoint inhibitor (ICI) activates host's anti-tumor immune response by blocking
negative regulatory immune signals. A series of clinical trials showed that ICI could …

Recent development of multi-target VEGFR-2 inhibitors for the cancer therapy

XJ Liu, HC Zhao, SJ Hou, HJ Zhang, L Cheng… - Bioorganic …, 2023 - Elsevier
Vascular epidermal growth factor receptor-2 (VEGFR-2), as an important tyrosine
transmembrane protein, plays an important role in regulating endothelial cell proliferation …

Anti-angiogenic tyrosine kinase inhibitors: what is their mechanism of action?

KJ Gotink, HMW Verheul - Angiogenesis, 2010 - Springer
Tyrosine kinases are important cellular signaling proteins that have a variety of biological
activities including cell proliferation and migration. Multiple kinases are involved in …

Pyridazine as a privileged structure: An updated review on anticancer activity of pyridazine containing bioactive molecules

ZX He, YP Gong, X Zhang, LY Ma, W Zhao - European journal of medicinal …, 2021 - Elsevier
Identification of potent anticancer agents with high selectivity and low toxicity remains on the
way to human health. Pyridazine featuring advantageous physicochemical properties and …

Role of the VEGF/VEGFR axis in cancer biology and therapy

A Rapisarda, G Melillo - Advances in cancer research, 2012 - Elsevier
New vessel formation (angiogenesis) is an essential physiological process for embryologic
development, normal growth, and tissue repair. Angiogenesis is tightly regulated at the …

Vascular endothelial growth factors and receptors: anti-angiogenic therapy in the treatment of cancer

S Tugues, S Koch, L Gualandi, X Li… - Molecular aspects of …, 2011 - Elsevier
Vascular endothelial growth factors (VEGFs) are critical regulators of vascular and lymphatic
function during development, in health and in disease. There are five mammalian VEGF …

Antiproliferative, antiangiogenic and apoptotic effect of new hybrids of quinazoline-4 (3H)-ones and sulfachloropyridazine

SS Zahran, FA Ragab, MG El-Gazzar… - European Journal of …, 2023 - Elsevier
Three new sets of quinazolinones bearing sulfachloropyridazine 4a-f, 6a-i and 8a-i were
designed and synthesized. All the synthesized compounds were screened for their in vitro …

Targeting cancer with small-molecular-weight kinase inhibitors

D Fabbro, SW Cowan-Jacob, H Möbitz… - … inhibitors: methods and …, 2011 - Springer
Protein and lipid kinases fulfill essential roles in many signaling pathways that regulate
normal cell functions. Deregulation of these kinase activities lead to a variety of pathologies …

Visible light amination/Smiles cascade: access to phthalazine derivatives

E Brachet, L Marzo, M Selkti, B König, P Belmont - Chemical Science, 2016 - pubs.rsc.org
We report the synthesis of various phthalazines via a new cascade reaction, initiated by
visible light photocatalysis, involving a radical hydroamination reaction followed by a radical …

Assessment of tumour hypoxia for prediction of response to therapy and cancer prognosis

AM Jubb, FM Buffa, AL Harris - Journal of cellular and …, 2010 - Wiley Online Library
Introduction• Pathological markers of hypoxia‐Necrosis‐Hypoxia inducible factor (HIF)
targets‐HIF‐1 versus HIF‐2‐Early versus late stage cancer‐Intratumour heterogeneity …